Turney Patricia A. 4/A
4/A · Arcutis Biotherapeutics, Inc. · Filed Aug 4, 2022
Insider Transaction Report
Form 4/AAmended
Turney Patricia A.
Senior VP, Manufacturing
Transactions
- Exercise/Conversion
Common Stock
2022-03-23$6.52/sh+15,331$99,958→ 46,444 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-23−15,331→ 144,612 totalExercise: $6.52Exp: 2029-11-20→ Common Stock (15,331 underlying)
Footnotes (2)
- [F1]Includes 24,925 restricted stock units.
- [F2]The option vests as to 1/4 of the total shares on November 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on November 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.